ClouDr (9955.HK) Signs Service Cooperation Agreement with JD Health (6618.HK) for Online Pharmaceutical Expansion

Bulletin Express

Yesterday

ClouDr (9955.HK) has announced a service cooperation agreement with JD Health (6618.HK) to expand online sales and service channels for Remifemin® and other P2M pipeline products. The arrangement aims to offer a more convenient purchasing experience and comprehensive health management support.

JD Health, as a significant pharmaceutical e-commerce platform with a substantial user base, is expected to bolster the reach of ClouDr’s cost-effective medications. ClouDr’s expertise in chronic disease management and unique product pipeline will, in turn, contribute to more efficient patient-doctor interaction and product promotion.

The Board of ClouDr confirms that JD Health is an independent third party. ClouDr intends to comply with relevant regulatory requirements in this cooperation process, cautioning shareholders and potential investors to exercise due care when trading its securities. The agreement was officially announced on November 13, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1151645734"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151645734\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151645734?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 12:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151645734","market":"us","top_or_hot":-1,"title":"ClouDr (9955.HK) Signs Service Cooperation Agreement with JD Health (6618.HK) for Online Pharmaceutical Expansion","media":"Bulletin Express","content":"<p>ClouDr (9955.HK) has announced a service cooperation agreement with JD Health (6618.HK) to expand online sales and service channels for Remifemin® and other P2M pipeline products. The arrangement aims to offer a more convenient purchasing experience and comprehensive health management support.</p>\n<p>JD Health, as a significant pharmaceutical e-commerce platform with a substantial user base, is expected to bolster the reach of ClouDr’s cost-effective medications. ClouDr’s expertise in chronic disease management and unique product pipeline will, in turn, contribute to more efficient patient-doctor interaction and product promotion.</p>\n<p>The Board of ClouDr confirms that JD Health is an independent third party. ClouDr intends to comply with relevant regulatory requirements in this cooperation process, cautioning shareholders and potential investors to exercise due care when trading its securities. The agreement was officially announced on November 13, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ClouDr (9955.HK) Signs Service Cooperation Agreement with JD Health (6618.HK) for Online Pharmaceutical Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClouDr (9955.HK) Signs Service Cooperation Agreement with JD Health (6618.HK) for Online Pharmaceutical Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-13 12:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ClouDr (9955.HK) has announced a service cooperation agreement with JD Health (6618.HK) to expand online sales and service channels for Remifemin® and other P2M pipeline products. The arrangement aims to offer a more convenient purchasing experience and comprehensive health management support.</p>\n<p>JD Health, as a significant pharmaceutical e-commerce platform with a substantial user base, is expected to bolster the reach of ClouDr’s cost-effective medications. ClouDr’s expertise in chronic disease management and unique product pipeline will, in turn, contribute to more efficient patient-doctor interaction and product promotion.</p>\n<p>The Board of ClouDr confirms that JD Health is an independent third party. ClouDr intends to comply with relevant regulatory requirements in this cooperation process, cautioning shareholders and potential investors to exercise due care when trading its securities. The agreement was officially announced on November 13, 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09955","symbol_name":"智云健康","start_time":0,"source_url":"","article_id":"1151645734","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151645734","pubTimestamp":1763007793,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"ClouDr (9955.HK) has announced a service cooperation agreement with JD Health (6618.HK) to expand online sales and service channels for Remifemin® and other P2M pipeline products. The arrangement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09955":"智云健康"},"translate_title":"ClouDr(9955.HK)与京东健康(6618.HK)签署在线医药扩张服务合作协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09955":1},"content_text":"ClouDr (9955.HK) has announced a service cooperation agreement with JD Health (6618.HK) to expand online sales and service channels for Remifemin® and other P2M pipeline products. The arrangement aims to offer a more convenient purchasing experience and comprehensive health management support.\nJD Health, as a significant pharmaceutical e-commerce platform with a substantial user base, is expected to bolster the reach of ClouDr’s cost-effective medications. ClouDr’s expertise in chronic disease management and unique product pipeline will, in turn, contribute to more efficient patient-doctor interaction and product promotion.\nThe Board of ClouDr confirms that JD Health is an independent third party. ClouDr intends to comply with relevant regulatory requirements in this cooperation process, cautioning shareholders and potential investors to exercise due care when trading its securities. The agreement was officially announced on November 13, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}